Categories: HealthcareNews

YoCierge Inc Achieves CARIN Code of Conduct for Consumer-Facing Applications Accreditation from DirectTrust®

Designation ensures a non-HIPAA covered Consumer-Facing Application adheres to the industry’s highest
standards and best practices while securely protecting and managing personally identifiable health
information

WAYNE, Pa.  , April 9, 2025 /PRNewswire/ — YoCierge Inc, a medical record retrieval company for the legal industry, announced today it has achieved Electronic Healthcare Network Accreditation Commission (EHNAC)-governed CARIN Code of Conduct for Consumer-Facing Applications Accreditation from DirectTrust®️.

Through a comprehensive independent third-party review, DirectTrust evaluated YoCierge Inc. for compliance with the CARIN Alliance Code of Conduct for Consumer-Facing Applications to ensure the application provides trusted, secure access and exchange of protected health information to all necessary stakeholders. The evaluation wholly examined application transparency, consent, use and disclosure, individual access, security, provenance, accountability and education for patients, providers, health plans, third party app developers and others.

“By achieving the CARIN Code of Conduct for Consumer-Facing Applications Accreditation from DirectTrust, YoCierge Inc has demonstrated their ability to provide consumers with secure and trusted access to their personal health data,” said Scott Stuewe, President and CEO, DirectTrust. “Attaining this accreditation is a significant achievement for YoCierge Inc in that it gives all healthcare stakeholders full confidence in the ability to exchange private and sensitive health information via an application that voluntarily sought verification to advance consumer-directed exchange.”

“At YoCierge, trust, transparency, and security have always been at the core of how we serve our clients. Earning the CARIN Code of Conduct for Consumer-Facing Applications accreditation from DirectTrust is not just a milestone—it’s a reflection of our deep commitment to protecting consumer health data and upholding the highest standards in data privacy and interoperability. We chose to pursue this accreditation with DirectTrust because of their industry leadership and rigorous standards, which align closely with our mission..” said George Bessenyei, CEO of YoCierge Inc.

About YoCierge

YoCierge is a premier provider of medical records retrieval and other legal support services, dedicated to empowering law firms with efficient, cost-effective, and secure solutions. By leveraging cutting-edge technology, YoCierge simplifies complex processes, enabling law firms to focus on what they do best—serving their clients. To learn more, visit: yocierge.com

About DirectTrust® 
DirectTrust® is a non-profit, vendor-neutral alliance dedicated to establishing trust in a connected world. The organization serves as a forum for a consensus-driven community focused on health communication and cybersecurity, an ANSI standards development organization, an accreditation and certification body governed by EHNAC, and a developer of technical trust frameworks and supportive services for secure information exchange like Direct Secure Messaging and identity-verified credentials.

The goal of DirectTrust is to develop, promote, and, as necessary, help enforce the rules and best practices necessary to maintain privacy, security, and trust for stakeholders across and beyond healthcare. In addition, DirectTrust is committed to fostering widespread public confidence in the interoperable exchange of health information while promoting quality service, innovation, cooperation, and open competition in healthcare. To learn more, visit: DirectTrust.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/yocierge-inc-achieves-carin-code-of-conduct-for-consumer-facing-applications-accreditation-from-directtrust-302424047.html

SOURCE Yocierge

Staff

Recent Posts

Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics

GENEVA, SWITZERLAND / ACCESS Newswire / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX)…

2 hours ago

Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia…

20 hours ago

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading…

20 hours ago

President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way

12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…

2 days ago

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…

2 days ago